Mesothelioma is a uncommon and quick acting tumor for which no helpful therapy exists even with the breakthrough of several potential molecular targets. The late stage of MPM diagnosis and the long time that exists between exposures and diagnosis have made it difficult to fully study what risk factors do and the insuing molecular effects.
Quite [...]